CN112753772A - Children growth milk and preparation method thereof - Google Patents
Children growth milk and preparation method thereof Download PDFInfo
- Publication number
- CN112753772A CN112753772A CN202011598533.6A CN202011598533A CN112753772A CN 112753772 A CN112753772 A CN 112753772A CN 202011598533 A CN202011598533 A CN 202011598533A CN 112753772 A CN112753772 A CN 112753772A
- Authority
- CN
- China
- Prior art keywords
- milk
- parts
- children
- growth
- raw
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013336 milk Nutrition 0.000 title claims abstract description 58
- 239000008267 milk Substances 0.000 title claims abstract description 58
- 210000004080 milk Anatomy 0.000 title claims abstract description 58
- 230000012010 growth Effects 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title abstract description 11
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims abstract description 36
- 239000005018 casein Substances 0.000 claims abstract description 35
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 35
- 235000021240 caseins Nutrition 0.000 claims abstract description 35
- 108010001441 Phosphopeptides Proteins 0.000 claims abstract description 34
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 23
- 235000010755 mineral Nutrition 0.000 claims abstract description 23
- 239000011707 mineral Substances 0.000 claims abstract description 23
- 239000002994 raw material Substances 0.000 claims abstract description 22
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims abstract description 18
- 229910000019 calcium carbonate Inorganic materials 0.000 claims abstract description 18
- 235000010216 calcium carbonate Nutrition 0.000 claims abstract description 18
- 239000004222 ferrous gluconate Substances 0.000 claims abstract description 18
- 235000013924 ferrous gluconate Nutrition 0.000 claims abstract description 18
- 229960001645 ferrous gluconate Drugs 0.000 claims abstract description 18
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 claims abstract description 18
- 239000011670 zinc gluconate Substances 0.000 claims abstract description 18
- 235000011478 zinc gluconate Nutrition 0.000 claims abstract description 18
- 229960000306 zinc gluconate Drugs 0.000 claims abstract description 18
- 229960003563 calcium carbonate Drugs 0.000 claims abstract description 9
- 235000020185 raw untreated milk Nutrition 0.000 claims description 24
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 18
- 102000010445 Lactoferrin Human genes 0.000 claims description 18
- 108010063045 Lactoferrin Proteins 0.000 claims description 18
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims description 18
- 229940078795 lactoferrin Drugs 0.000 claims description 18
- 235000021242 lactoferrin Nutrition 0.000 claims description 18
- 239000000787 lecithin Substances 0.000 claims description 18
- 235000010445 lecithin Nutrition 0.000 claims description 18
- 229940067606 lecithin Drugs 0.000 claims description 18
- 239000004386 Erythritol Substances 0.000 claims description 17
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 17
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 17
- 229940009714 erythritol Drugs 0.000 claims description 17
- 235000019414 erythritol Nutrition 0.000 claims description 17
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 17
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 17
- 239000000811 xylitol Substances 0.000 claims description 17
- 229960002675 xylitol Drugs 0.000 claims description 17
- 235000010447 xylitol Nutrition 0.000 claims description 17
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 17
- 102000007544 Whey Proteins Human genes 0.000 claims description 16
- 108010046377 Whey Proteins Proteins 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 16
- 235000021119 whey protein Nutrition 0.000 claims description 16
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 15
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 15
- 229920002148 Gellan gum Polymers 0.000 claims description 14
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 14
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 14
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 14
- 239000000679 carrageenan Substances 0.000 claims description 14
- 235000010418 carrageenan Nutrition 0.000 claims description 14
- 229920001525 carrageenan Polymers 0.000 claims description 14
- 229940113118 carrageenan Drugs 0.000 claims description 14
- 239000000216 gellan gum Substances 0.000 claims description 14
- 235000010492 gellan gum Nutrition 0.000 claims description 14
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 14
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 14
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 14
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 14
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 14
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 12
- 239000003381 stabilizer Substances 0.000 claims description 11
- 235000003599 food sweetener Nutrition 0.000 claims description 7
- 239000003765 sweetening agent Substances 0.000 claims description 7
- 238000007872 degassing Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 235000013406 prebiotics Nutrition 0.000 claims description 5
- 235000020209 toddler milk formula Nutrition 0.000 claims description 4
- 238000011049 filling Methods 0.000 claims description 2
- 238000009928 pasteurization Methods 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract description 17
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 9
- 239000011575 calcium Substances 0.000 abstract description 9
- 229910052791 calcium Inorganic materials 0.000 abstract description 9
- 230000036039 immunity Effects 0.000 abstract description 9
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract description 8
- 239000011701 zinc Substances 0.000 abstract description 8
- 229910052725 zinc Inorganic materials 0.000 abstract description 8
- 208000008589 Obesity Diseases 0.000 abstract description 6
- 235000020824 obesity Nutrition 0.000 abstract description 6
- 230000004641 brain development Effects 0.000 abstract description 4
- 208000002925 dental caries Diseases 0.000 abstract description 2
- 238000012545 processing Methods 0.000 abstract description 2
- 239000013589 supplement Substances 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 12
- 230000001737 promoting effect Effects 0.000 description 11
- 241000700159 Rattus Species 0.000 description 8
- 238000011161 development Methods 0.000 description 8
- 230000018109 developmental process Effects 0.000 description 8
- 229910052742 iron Inorganic materials 0.000 description 8
- 239000000126 substance Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 235000013350 formula milk Nutrition 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000014461 bone development Effects 0.000 description 2
- 210000004958 brain cell Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 235000005135 Micromeria juliana Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 241000246354 Satureja Species 0.000 description 1
- 235000007315 Satureja hortensis Nutrition 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000020785 dietary preference Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000037345 metabolism of vitamins Effects 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 229940029985 mineral supplement Drugs 0.000 description 1
- 235000020786 mineral supplement Nutrition 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 230000030363 nerve development Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1522—Inorganic additives, e.g. minerals, trace elements; Chlorination or fluoridation of milk; Organic salts or complexes of metals other than natrium or kalium; Calcium enrichment of milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1526—Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/156—Flavoured milk preparations ; Addition of fruits, vegetables, sugars, sugar alcohols or sweeteners
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention relates to the technical field of processing of modified milk, in particular to children growth milk and a preparation method thereof; the children growth milk is prepared from raw materials including casein phosphopeptides and minerals, wherein the minerals are prepared from the following components in percentage by mass (0.65-0.85): (0.09-0.16): (0.04-0.065) calcium carbonate, ferrous gluconate and zinc gluconate; the mass ratio of the casein phosphopeptide to the mineral is (1.0-1.6): (0.78-1.075). The milk for children growth can supplement daily required calcium, ferrum and zinc for children, prevent dental caries, prevent obesity, enhance immunity, and assist brain development of children.
Description
Technical Field
The invention relates to the technical field of modified milk processing, in particular to children growth milk and a preparation method thereof, and the modified milk is particularly suitable for children in a growth and development period to drink.
Background
The calcium has physiological functions of promoting the growth and development of bones and teeth, the growth, development and maturation of brain cells, maintaining the normal functions of the cells, regulating the pH value of blood, balancing electrolytes and the like. Iron is an important component of hemoglobin, is one of essential elements for brain nerve development, participates in energy metabolism and hematopoiesis in the body, provides nutrients for brain cells and influences nerve conduction. Zinc is involved in the synthesis of various enzymes and proteins in vivo, is a key nutrient for the development of the central nervous system, and has the effects of improving the immunity of the organism, promoting the metabolism of vitamin A, improving the intelligence and the like. The childhood stage is the fastest bone development stage, the most critical bone development stage and the rapid intelligence development stage, and the proper mineral supplement in the diet is crucial to the maintenance of healthy growth and development of children.
The absorption and utilization degree of minerals by human bodies depends on the inherent content of mineral components in food, and is also closely related to factors such as personal physique, dietary structure and the like. Therefore, there is a need for a child growth milk that promotes mineral absorption to meet the nutritional needs of the child in the growth stage.
In view of this, the invention is particularly proposed.
Disclosure of Invention
The invention aims to provide the children growth milk which can supplement calcium, iron and zinc required by children every day, prevent decayed teeth, prevent obesity, enhance the immunity of organisms and assist the brain development of the children; the invention also aims to provide a preparation method of the children growth milk.
Specifically, the invention provides the following technical scheme:
the invention provides children growth milk which is prepared from raw materials comprising casein phosphopeptides and minerals, wherein the minerals are prepared from the following components in percentage by mass (0.65-0.85): (0.09-0.16): (0.04-0.065) calcium carbonate, ferrous gluconate and zinc gluconate;
the mass ratio of the casein phosphopeptide to the mineral is (1.0-1.6): (0.78-1.075).
The invention discovers that casein phosphopeptide and calcium carbonate are combined to form soluble salt in a specific ratio, and the detention time of calcium in vivo is prolonged, so that the bioavailability of calcium is effectively improved; meanwhile, the casein phosphopeptide interacts with ferrous gluconate and zinc gluconate according to a specific dosage ratio to promote the absorption of iron and zinc by the body.
Furthermore, the casein phosphopeptide is a bioactive peptide obtained by hydrolyzing cow milk casein serving as a raw material with pancreatin or trypsin.
In the invention, the casein phosphopeptide has the physiological functional activities of preventing decayed teeth, improving the immunity of organisms and inducing the apoptosis of tumor cells besides the function of promoting the absorption of mineral substances.
Preferably, the casein phosphopeptide is milk-derived casein phosphopeptide; the milk product can promote the absorption of the mineral substances by the body by adopting the compounding of the milk-derived casein phosphopeptide and the mineral substances.
Preferably, the raw materials also comprise raw milk, a sweetening agent, whey protein powder, prebiotics, a stabilizing agent, lecithin and lactoferrin.
Preferably, the protein content in the raw milk is more than or equal to 3.2g/100 g; the best results are obtained when the protein content of the raw milk is within the above range.
Preferably, the raw material system of the invention is compounded with a sweetening agent according to the mass ratio of (10-30): (10-30) xylitol and erythritol; the compound sweetening agent not only can endow children with better sweetness for growing up milk, but also can not generate adverse effect on the texture characteristics of a system and can not reduce the function of the milk; in addition, the compound sweetening agent can improve the flavor of milk and prevent the occurrence of obesity and decayed teeth of children.
Preferably, for the raw material system of the invention, the prebiotics compounded with the raw material system is fructo-oligosaccharide; besides providing sweet taste and increasing flavor, the product also has the functions of promoting intestinal probiotic proliferation, reducing blood lipid and cholesterol levels, preventing dental caries, improving immunity, promoting mineral absorption, etc.
Preferably, the stabilizer is one or more selected from microcrystalline cellulose, gellan gum, carrageenan and sodium carboxymethylcellulose.
Preferably, the invention provides the following raw material formula of the children growth milk, which specifically comprises the following components in parts by weight: 905-960 parts of raw milk, 10-30 parts of xylitol, 10-30 parts of erythritol, 10-20 parts of whey protein powder, 2-4 parts of fructo-oligosaccharide, 1.5-4 parts of a stabilizer, 1-2 parts of lecithin, 1.0-1.6 parts of casein phosphopeptide, 0.5-1 part of lactoferrin, 0.65-0.85 part of calcium carbonate, 0.09-0.16 part of ferrous gluconate and 0.04-0.065 part of zinc gluconate.
The children growth milk prepared by the raw material formula has the effect of promoting the body to absorb mineral substances, also has the effects of preventing decayed teeth, preventing obesity, enhancing the body immunity, assisting the brain development and the like, and meets the nutritional requirements of children in a growth period; in addition, the children growth milk has savory and mellow taste; the comprehensive performance of the milk product for the growth of children is excellent.
Preferably, the raw material system of the invention is compounded with the stabilizer in a mass ratio of (1-2): (0.5-0.6): (0.2-0.5): (0.1-0.3) microcrystalline cellulose, gellan gum, carrageenan and sodium carboxymethylcellulose; the stabilizer can realize good texture of milk for children growth, has good stability in normal storage and transportation processes, is not easy to separate out water and layer, avoids the problem of fat floating, and better ensures the taste of the product.
As a better technical scheme of the invention, the raw materials of the children growth milk comprise the following components in parts by weight: 930-935 parts of raw milk, 10-20 parts of xylitol, 20-30 parts of erythritol, 10-20 parts of whey protein powder, 2-4 parts of fructo-oligosaccharide, 1-2 parts of microcrystalline cellulose, 0.5-0.6 part of gellan gum, 0.2-0.5 part of carrageenan, 0.1-0.3 part of sodium carboxymethylcellulose, 1-2 parts of lecithin, 1.0-1.6 parts of casein phosphopeptide, 0.5-1 part of lactoferrin, 0.65-0.8 part of calcium carbonate, 0.09-0.16 part of ferrous gluconate and 0.04-0.065 part of zinc gluconate.
In the raw material formula, the lecithin not only has the nutrition function, but also has the effects of strengthening brain function, enhancing memory, improving learning efficiency, regulating organism metabolism and reducing cholesterol level; the lactoferrin not only provides nutrition, but also has physiological functions of enhancing the immunity of the organism, improving the bioavailability of iron, resisting virus, tumor and oxidation.
In conclusion, the raw material formula of the children growth milk provided by the invention takes xylitol and erythritol as sweetening agents, meets the requirements of children on taste, is added with specific mineral substances, prebiotics, lecithin and functional factors with bioactivity of lactoferrin, and is particularly added with casein phosphopeptides, so that the bioavailability of mineral elements is improved, and the milk has the functions of preventing decayed teeth, obesity and regulating the immunity of organisms while meeting the nutritional requirements of children on body development and intelligence development in the growth stage.
The invention also provides a preparation method of the children growth milk, which comprises the following steps:
(1) uniformly mixing xylitol, erythritol, whey protein powder, fructo-oligosaccharide, a stabilizer, lecithin, casein phosphopeptide, lactoferrin, calcium carbonate, ferrous gluconate and zinc gluconate to obtain a premix;
(2) mixing the raw milk and the premix, stirring until the raw milk and the premix are completely dissolved, degassing, homogenizing, pasteurizing and filling.
Preferably, the raw milk is preheated to 50-55 ℃.
Preferably, the homogenizing pressure is 15-20 MPa, and the temperature is 55-65 ℃; the homogenization is carried out under the conditions, which is beneficial to improving the stability of the product.
And/or the pasteurization is carried out for 15-30 s at the temperature of 72-85 ℃.
The invention has the beneficial effects that:
the invention provides the children growth milk capable of promoting mineral substance absorption, which has good texture characteristics and stability, is not easy to separate water and layer in the normal storage and transportation process, and avoids fat floating; meanwhile, the children growth milk is smooth in taste and free of granular sensation when being eaten, and can prevent decayed teeth, prevent obesity, enhance organism immunity and assist brain development of children on the basis of promoting the children organism to absorb mineral substances.
Detailed Description
The following examples are intended to illustrate the invention but are not intended to limit the scope of the invention.
The protein content of raw milk used in the following examples is not less than 3.2g/100g, and casein phosphopeptide is milk-derived casein phosphopeptide.
Example 1
The embodiment provides children growth milk which comprises the following raw materials:
930g of raw milk, 10g of xylitol, 30g of erythritol, 20g of whey protein powder, 3g of fructo-oligosaccharide, 1g of microcrystalline cellulose, 0.5g of gellan gum, 0.5g of carrageenan, 0.3g of sodium carboxymethylcellulose, 1.0g of lecithin, 1.0g of casein phosphopeptide, 1g of lactoferrin, 0.7g of calcium carbonate, 0.16g of ferrous gluconate and 0.065g of zinc gluconate.
The embodiment also provides a preparation method of the children growth milk, which comprises the following steps:
(1) uniformly mixing xylitol, erythritol, whey protein powder, fructo-oligosaccharide, microcrystalline cellulose, gellan gum, carrageenan, sodium carboxymethylcellulose, lecithin, casein phosphopeptide, lactoferrin, calcium carbonate, ferrous gluconate and zinc gluconate to obtain a premix;
(2) heating raw milk to 50 deg.C by plate heat exchange equipment, mixing with the premix, stirring to dissolve completely, degassing, homogenizing (15MPa, 60 deg.C), pasteurizing (85 deg.C, 15s), and packaging.
Example 2
The embodiment provides children growth milk which comprises the following raw materials:
raw milk 935g, xylitol 20g, erythritol 20g, whey protein powder 15g, fructo-oligosaccharide 4g, microcrystalline cellulose 2g, gellan gum 0.5g, carrageenan 0.3g, sodium carboxymethylcellulose 0.1g, lecithin 2g, casein phosphopeptide 1.5g, lactoferrin 0.5g, calcium carbonate 0.8g, ferrous gluconate 0.1g, and zinc gluconate 0.05 g.
The embodiment also provides a preparation method of the children growth milk, which comprises the following steps:
(1) uniformly mixing xylitol, erythritol, whey protein powder, fructo-oligosaccharide, microcrystalline cellulose, gellan gum, carrageenan, sodium carboxymethylcellulose, lecithin, casein phosphopeptide, lactoferrin, calcium carbonate, ferrous gluconate and zinc gluconate to obtain a premix;
(2) heating raw milk to 55 deg.C by plate heat exchange equipment, mixing with the premix, stirring to dissolve completely, degassing, homogenizing (20Mpa, 65 deg.C), pasteurizing (75 deg.C, 30s), and packaging.
Example 3
The embodiment provides children growth milk which comprises the following raw materials:
930g of raw milk, 20g of xylitol, 30g of erythritol, 10g of whey protein powder, 2g of fructo-oligosaccharide, 1.2g of microcrystalline cellulose, 0.6g of gellan gum, 0.2g of carrageenan, 0.1g of sodium carboxymethylcellulose, 1.5g of lecithin, 1.4g of casein phosphopeptide, 0.7g of lactoferrin, 0.65g of calcium carbonate, 0.15g of ferrous gluconate and 0.04g of zinc gluconate.
The embodiment also provides a preparation method of the children growth milk, which comprises the following steps:
(1) uniformly mixing xylitol, erythritol, whey protein powder, fructo-oligosaccharide, microcrystalline cellulose, gellan gum, carrageenan, sodium carboxymethylcellulose, lecithin, casein phosphopeptide, lactoferrin, calcium carbonate, ferrous gluconate and zinc gluconate to obtain a premix;
(2) heating raw milk to 50 deg.C by plate heat exchange equipment, mixing with the premix, stirring to dissolve completely, degassing, homogenizing (17MPa, 55 deg.C), pasteurizing (80 deg.C, 20s), and packaging.
Example 4
The embodiment provides children growth milk which comprises the following raw materials:
930g of raw milk, 15g of xylitol, 25g of erythritol, 17g of whey protein powder, 3.5g of fructo-oligosaccharide, 1.4g of microcrystalline cellulose, 0.6g of gellan gum, 0.4g of carrageenan, 0.2g of sodium carboxymethylcellulose, 1.8g of lecithin, 1.6g of casein phosphopeptide, 0.9g of lactoferrin, 0.75g of calcium carbonate, 0.09g of ferrous gluconate, and 0.06g of zinc gluconate.
The embodiment also provides a preparation method of the children growth milk, which comprises the following steps:
(1) uniformly mixing xylitol, erythritol, whey protein powder, fructo-oligosaccharide, microcrystalline cellulose, gellan gum, carrageenan, sodium carboxymethylcellulose, lecithin, casein phosphopeptide, lactoferrin, calcium carbonate, ferrous gluconate and zinc gluconate to obtain a premix;
(2) heating raw milk to 55 deg.C by plate heat exchange equipment, mixing with the premix, stirring to dissolve completely, degassing, homogenizing (16MPa, 60 deg.C), pasteurizing (85 deg.C, 20s), and packaging.
Comparative example 1:
this comparative example provides a child growth milk, differing from example 1 only in that: replacing casein phosphopeptide with vitamin D; wherein the addition amount of vitamin D is 10 mg.
Comparative example 2:
this comparative example provides a child growth milk, differing from example 1 only in that: the preparation raw materials do not contain casein phosphopeptide.
Test example 1:
in the experimental example, the efficacy of promoting mineral absorption was verified for the children growth milk prepared in example 1 and comparative examples 1 to 2, specifically as follows:
SD rats are fed with the mineral absorption promoting children growth milk prepared in example 1 and comparative examples 1-2, and the apparent absorption rates of the rats on calcium, iron and zinc and the contents of calcium, iron and zinc in serum are measured during normal diet and drinking water of the SD rats during feeding. The results are shown in tables 1 and 2;
TABLE 1
As can be seen from table 1, compared to comparative example 2, example 1 can simultaneously promote the absorption of calcium, iron and zinc in SD rats, while comparative example 1 can only promote the absorption of calcium element.
TABLE 2
As can be seen from Table 2, the serum calcium content of SD rats fed with the growth milk of children of example 1 and comparative example 1 was higher than that of SD rats fed with the growth milk of children of comparative example 2, and the serum iron and zinc contents of SD rats fed with the growth milk of children of example 1 were higher than those of SD rats fed with the growth milk of children of comparative example 1 and comparative example 2.
In conclusion, the children growth milk has better effect of promoting mineral absorption.
Test example 2:
in the present test example, sensory evaluation analysis was performed on the children's growing-up milk of examples 1 to 4, specifically as follows:
40 children (half of all the men and women) aged 8-16 are selected to perform sensory evaluation on the children growth milk of the embodiments 1-4, and specific evaluation indexes include flavor (whether the milk is strong and peculiar smell exists), taste (whether the milk is smooth and fine), sweetness (whether the sweetness is proper) and overall characteristics. The evaluation criteria are divided into three grades of like, general and dislike. The results are shown in Table 3;
TABLE 3
As can be seen from Table 3, the children growth milk provided by the invention has the advantages that the flavor, the taste, the sweetness and the overall characteristics are more in line with the dietary preference of children, and the preference degree of children is higher.
Although the invention has been described in detail hereinabove by way of general description, specific embodiments and experiments, it will be apparent to those skilled in the art that many modifications and improvements can be made thereto based on the invention. Accordingly, such modifications and improvements are intended to be within the scope of the invention as claimed.
Claims (10)
1. The children growth milk is characterized by being prepared from raw materials comprising casein phosphopeptides and minerals, wherein the minerals are prepared from the following components in percentage by mass (0.65-0.85): (0.09-0.16): (0.04-0.065) calcium carbonate, ferrous gluconate and zinc gluconate;
the mass ratio of the casein phosphopeptide to the mineral is (1.0-1.6): (0.78-1.075).
2. The children's growing up milk of claim 1, wherein the casein phosphopeptide is a milk-derived casein phosphopeptide.
3. The children's growth milk according to claim 1 or 2, wherein the raw materials further comprise raw milk, a sweetener, whey protein powder, prebiotics, a stabilizer, lecithin and lactoferrin.
4. The children's growing up milk of claim 3, wherein the protein content in the raw milk is not less than 3.2g/100 g;
and/or the sweetener is prepared from the following components in percentage by mass (10-30): (10-30) xylitol and erythritol;
and/or the prebiotics are fructooligosaccharides;
and/or the stabilizer is one or more selected from microcrystalline cellulose, gellan gum, carrageenan and sodium carboxymethylcellulose.
5. The children growth milk according to claim 4, wherein the raw materials comprise the following components in parts by weight: 905-960 parts of raw milk, 10-30 parts of xylitol, 10-30 parts of erythritol, 10-20 parts of whey protein powder, 2-4 parts of fructo-oligosaccharide, 1.5-4 parts of a stabilizer, 1-2 parts of lecithin, 1.0-1.6 parts of casein phosphopeptide, 0.5-1 part of lactoferrin, 0.65-0.85 part of calcium carbonate, 0.09-0.16 part of ferrous gluconate and 0.04-0.065 part of zinc gluconate.
6. The children growth milk according to claim 5, wherein the stabilizer is prepared from (1-2) by mass: (0.5-0.6): (0.2-0.5): (0.1-0.3) microcrystalline cellulose, gellan gum, carrageenan and sodium carboxymethylcellulose.
7. The children growth milk according to claim 5 or 6, wherein the raw materials comprise the following components in parts by weight: 930-935 parts of raw milk, 10-20 parts of xylitol, 20-30 parts of erythritol, 10-20 parts of whey protein powder, 2-4 parts of fructo-oligosaccharide, 1-2 parts of microcrystalline cellulose, 0.5-0.6 part of gellan gum, 0.2-0.5 part of carrageenan, 0.1-0.3 part of sodium carboxymethylcellulose, 1-2 parts of lecithin, 1.0-1.6 parts of casein phosphopeptide, 0.5-1 part of lactoferrin, 0.65-0.8 part of calcium carbonate, 0.09-0.16 part of ferrous gluconate and 0.04-0.065 part of zinc gluconate.
8. The method for preparing children's growth milk according to any one of claims 1 to 7, comprising:
(1) uniformly mixing xylitol, erythritol, whey protein powder, fructo-oligosaccharide, a stabilizer, lecithin, casein phosphopeptide, lactoferrin, calcium carbonate, ferrous gluconate and zinc gluconate to obtain a premix;
(2) mixing the raw milk and the premix, stirring until the raw milk and the premix are completely dissolved, degassing, homogenizing, pasteurizing and filling.
9. The method according to claim 8, wherein the raw milk is preheated to 50-55 ℃.
10. The method according to claim 8 or 9, wherein the homogenizing pressure is 15 to 20MPa and the temperature is 55 to 65 ℃;
and/or the pasteurization is carried out for 15-30 s at the temperature of 72-85 ℃.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011598533.6A CN112753772A (en) | 2020-12-29 | 2020-12-29 | Children growth milk and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011598533.6A CN112753772A (en) | 2020-12-29 | 2020-12-29 | Children growth milk and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112753772A true CN112753772A (en) | 2021-05-07 |
Family
ID=75696863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011598533.6A Pending CN112753772A (en) | 2020-12-29 | 2020-12-29 | Children growth milk and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112753772A (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101690590A (en) * | 2009-10-15 | 2010-04-07 | 南宁富莱欣生物科技有限公司 | Health-care food of iron zinc calcium tablets and production method thereof |
| CN103783238A (en) * | 2014-01-23 | 2014-05-14 | 甘南倍益特生物科技有限公司 | Yak milk protein sugar beneficial for children intelligence and preparation method thereof |
| CN105076403A (en) * | 2014-05-07 | 2015-11-25 | 保龄宝生物股份有限公司 | Dental caries resistant milk product containing erythritol |
| CN105076425A (en) * | 2015-09-17 | 2015-11-25 | 许德建 | Yak, cow and ewe three-in-one composite infant formula milk powder |
| CN106172788A (en) * | 2016-08-05 | 2016-12-07 | 南京卫岗乳业有限公司 | High calcium milk and preparation method thereof |
| CN111616232A (en) * | 2020-06-12 | 2020-09-04 | 北安宜品努卡乳业有限公司 | Children milk powder for promoting bone growth and preparation method thereof |
| CN111887298A (en) * | 2020-08-06 | 2020-11-06 | 湖北咸宁向阳湖兴兴奶业有限公司 | Formula of high-calcium goat milk powder for children growth |
-
2020
- 2020-12-29 CN CN202011598533.6A patent/CN112753772A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101690590A (en) * | 2009-10-15 | 2010-04-07 | 南宁富莱欣生物科技有限公司 | Health-care food of iron zinc calcium tablets and production method thereof |
| CN103783238A (en) * | 2014-01-23 | 2014-05-14 | 甘南倍益特生物科技有限公司 | Yak milk protein sugar beneficial for children intelligence and preparation method thereof |
| CN105076403A (en) * | 2014-05-07 | 2015-11-25 | 保龄宝生物股份有限公司 | Dental caries resistant milk product containing erythritol |
| CN105076425A (en) * | 2015-09-17 | 2015-11-25 | 许德建 | Yak, cow and ewe three-in-one composite infant formula milk powder |
| CN106172788A (en) * | 2016-08-05 | 2016-12-07 | 南京卫岗乳业有限公司 | High calcium milk and preparation method thereof |
| CN111616232A (en) * | 2020-06-12 | 2020-09-04 | 北安宜品努卡乳业有限公司 | Children milk powder for promoting bone growth and preparation method thereof |
| CN111887298A (en) * | 2020-08-06 | 2020-11-06 | 湖北咸宁向阳湖兴兴奶业有限公司 | Formula of high-calcium goat milk powder for children growth |
Non-Patent Citations (1)
| Title |
|---|
| 邹远东, 知识产权出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2524241C2 (en) | Pea based protein mixture and its application in liquid nutritional composition suitable for enteral feeding | |
| EP1199946B1 (en) | Gelled nutritional composition | |
| CN101548698B (en) | Humanized milk and preparation method thereof | |
| CN107232424B (en) | Pet chaotropic agent and preparation method thereof | |
| US9386791B2 (en) | Dairy product and process | |
| JP5077982B2 (en) | Fat accumulation inhibitor | |
| CN106605709B (en) | Liquid milk suitable for children of 3-6 years old and preparation method thereof | |
| CN107455636A (en) | A kind of clear transparent beverage of albumin milk and preparation method thereof | |
| CN101766226A (en) | Liquid dairy product containing oligomate and dietary fiber and preparation method thereof | |
| CN102264379A (en) | Muscle-building agent | |
| US5411757A (en) | Palatable balanced amino acid-modified diet | |
| JP5465834B2 (en) | Liver function protectant | |
| JP5384333B2 (en) | Liquid nutritional composition containing whey protein at high concentration and method for producing the same | |
| CN107467203A (en) | A kind of clear transparent beverage of albumin milk and preparation method thereof | |
| JP2005013134A (en) | Gel-shaped food composition | |
| CN105076418A (en) | Infant formula milk powder for promoting development of brain nerves and gastrointestinal tissues of infants | |
| US20060062827A1 (en) | Nutritional supplement composition and method | |
| CN104507334A (en) | Novel protein material | |
| JP5789981B2 (en) | Liquid nutrition composition | |
| CN112753772A (en) | Children growth milk and preparation method thereof | |
| CN104430889A (en) | Goat milk powder formula for middle and old age people as well as preparation method and application of goat milk powder formula for middle and old age people | |
| JP7025112B2 (en) | BDNF production promoter | |
| JP7372046B2 (en) | peptide | |
| CN109874870A (en) | A kind of infant milk powder of simulation breast milk proteins composition and immune function | |
| JP6885676B2 (en) | Obesity suppressant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210507 |
|
| RJ01 | Rejection of invention patent application after publication |